Skip to content

Clinical trials

Phase 1 Lymphoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1 Country / region: United Kingdom Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20062
20074
20081
20091
20101
20113
20122
20132
20143
20151
20162
20174
20192
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated5
Unknown status3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK3
University College, London3
Bayer2
Celgene2
Eisai Inc.2
Eli Lilly and Company2
ADC Therapeutics S.A.1
Acerta Pharma BV1
Arno Therapeutics1
Astellas Pharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma36
Neoplasms9
Lymphoma, Non-Hodgkin6
Leukemia5
Lymphoma, Large B-Cell, Diffuse4
Neoplasms, Plasma Cell4
Breast Neoplasms3
Head and Neck Neoplasms3
Hematologic Neoplasms3
Hodgkin Disease3

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.